Advertisement

Topics

Systems pharmacology modelers accelerate drug discovery in Alzheimer's

20:00 EDT 20 Jun 2017 | AAAS

(Institute for Systems Biology Moscow) InSysBio scientific group led by Tatiana Karelina developed a quantitative system pharmacology model of Alzheimer's disease. First part published in CPT Pharmacometrics & Systems Pharmacology shows how to design initial phases of clinical trials of new drugs and to interpret the data obtained.

Original Article: Systems pharmacology modelers accelerate drug discovery in Alzheimer's

NEXT ARTICLE

More From BioPortfolio on "Systems pharmacology modelers accelerate drug discovery in Alzheimer's"

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...